The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the idenfication of numerous naturally occurring endogenous peptides which act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems. The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials. Original papers predominate. Manuscripts may be of any length, but must be complete studies; preliminary communications are not accepted. Review articles and hypothesis papers are welcomed, and will be evaluated in the same way as experimental papers. Authors intending to submit a review are advised to communicate their intentions to the Editors, to avoid possible duplication.

神經肽的目的是快速發(fā)表關于肽在中樞和外周神經系統中的結構、分布、作用和功能的原始研究和綜述文章。這一領域的研究活動激增，導致許多天然內源性肽的鑒定，這些肽作為神經遞質、神經調節(jié)劑或營養(yǎng)因子，介導神經系統功能。越來越多的神經肽受體的非肽配體被開發(fā)出來，它們在肽能系統中起激動劑或拮抗劑的作用。該雜志提供了一個獨特的機會，整合了涉及所有神經肽研究的許多學科。該雜志發(fā)表的文章涉及神經肽領域的各個方面，特別強調肽表達的基因調控、肽受體亞型、神經肽和肽受體基因突變的轉基因和敲除小鼠、神經解剖學、生理學、行為學、神經營養(yǎng)因子、臨床前藥物評價、臨床研究和臨床試驗。原始論文占主導地位。手稿可以是任何長度，但必須是完整的研究報告;不接受初步通訊。歡迎評論文章和假設論文，并將以與實驗論文相同的方式進行評估。建議打算提交評論的作者與編輯溝通他們的意圖，以避免可能的重復。